INTERESTED IN THIS RESEARCH?
Contact our analysts for inquiries, samples, and expert insights.
Report Outlook
| Market Size | CAGR | Dominating Region |
|---|---|---|
| USD 50.31 billion by 2029 | 6.8% | North America |
| By Product | By Type Of Testing | By Technolgy | By Disease Type |
|---|---|---|---|
|
|
|
|
SCOPE OF THE REPORT
Infectious Disease Diagnostics Market Overview
Infectious disease diagnostics market is expected to grow at 6.8% CAGR from 2022 to 2029. It was valued 26.06 billion at 2020. It is expected to reach above USD 50.31 billion by 2029.Â
The increasing awareness of early disease detection, the frequency of infectious diseases around the world, the shift in emphasis from centralized laboratories to decentralized POC testing, and technical improvements are all factors driving market expansion.
The infectious disease diagnostics caused by pathogens like viruses, fungus, bacteria, or parasites. Through direct contact, indirect contact, insect bites, or other means such as food, soil, water, and air, infectious diseases can be transmitted from one person to another. By examining the patient’s symptoms, a diagnosis is made by determining the underlying causes. It is crucial in determining how to properly treat infectious infections and other illnesses.
| ATTRIBUTE | DETAILS |
| Study period | 2020-2029 |
| Base year | 2021 |
| Estimated year | 2022 |
| Forecasted year | 2022-2029 |
| Historical period | 2018-2020 |
| Unit | Value (USD Billion, Thousand Units) |
| Segmentation | By Product, By type of testing, By technology, By disease type, By end user |
| By Product |
|
| By Type of testing |
|
| By Technology |
|
| By Disease type | |
| By End user |
|
| By Region |
|
Infectious disease transmission between developed and developing regions will benefit diagnostics. Diagnostic tests for infectious diseases are being prescribed more frequently to help in the diagnosis and treatment of these illnesses. The demand for infectious disease diagnostics is anticipated to rise throughout the projected period as a result of these factors and the expanding trend of preventive medicine.The rising prevalence of infectious diseases, the shift in emphasis from centralized laboratories to point-of-care testing, and increased R&D activity on infectious disease diagnostics are the main drivers of the market’s growth. The rapid diagnostic strategy for disease detection is evolving due to scientific research and development efforts to create new technologies and techniques, such as mass spectrometry and next-generation sequencing (NGS), which is causing the infectious disease diagnostics market to expand.
Infectious Disease Diagnostics Market Segment Analysis
Infectious disease diagnostics market is segmented based on product, type of testing, technology, disease type, end user and region, global trends and forecast.
By product the market is segmented into reagents, kits and consumables, instruments, software & services. The market was dominated by the assays & reagents segment in 2020, and this trend is anticipated to persist over the course of the forecast period due to an increase in R&D activities in the pharmaceutical & biotechnology sector, an increase in demand for reagents, and a surge in the uptake of point-of-care testing. However, the instruments market is predicted to expand significantly over the course of the projection year due to an increase in research laboratories and increased funding from public and commercial organizations for the creation of diagnostic tools for the pharmaceutical and biotechnology sectors.
By type of testing the market is segmented into laboratory testing, POC testing. By technology the market is segmented into immunodiagnostics, clinical microbiology, PCR, INAAT, DNA sequencing & NGS, DNA microarray, other technologies. Due to a large number of key players offering advanced diagnostic medical devices, an increase in demand for DNA analysis, the development of novel and innovative PCR tools, and advancements in R&D activities for infectious disease diagnosis, the others segment dominated the market in 2020, and this trend is anticipated to continue during the forecast period. But due to the rise in genomic projects, increased public awareness of DNA sequencing, and improvements in R&D for DNA analysis activities, the immunodiagnostic segment is anticipated to have significant growth during the projection period.
By disease type the market is segmented into covid-19, HIV, hepatitis, influenza and other infectious diseases. Due to the rise in the prevalence of infections connected with healthcare, the rise in surgical procedures, and the rising demand for early diagnostic, the others category was the largest contributor in 2020 and is anticipated to retain its lead during the projection period. However, the hepatitis segment is anticipated to grow significantly over the course of the projection period due to rising hepatitis prevalence, increased need for early diagnosis, and the development of modern diagnostic labs in hospitals and clinics.
By end user the market is segmented into diagnostics laboratories, hospitals & clinics, academic research institutes and other end users. Due to high procedure volumes and market penetration, the segment of diagnostic laboratories held a dominant position in the market for infectious disease molecular diagnostics in 2020 and contributed the biggest revenue share of 76.5%. Another significant factor projected to propel the market for infectious disease molecular diagnostics is the growing number of initiatives done by the government to provide various services, such as diagnostic test reimbursements.
Infectious Disease Diagnostics Market Key Players
Infectious disease diagnostics market key players include Abbott laboratories, Danaher Corporation, bioMérieux SA, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, Hologic, Inc. (Gen-Probe), Illumina, Inc., Grifols S.A., Qiagen, Siemens Healthineers AG, Sysmex Corporation.
Industry Development:
- March 27, 2020: Abbott laboratories announced that the fastest molecular point-of-care test for the detection of novel coronavirus (COVID-19), which can yield positive results in as little as five minutes and negative results in 13 minutes, had received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The test will be carried out using the company’s ID NOWTM platform, which offers quick results in a variety of healthcare settings, including doctor’s offices, urgent care centers, and hospital emergency rooms.
- February 1, 2023: Launch of MAESTRIATM by bioMérieux, a leader in in vitro diagnostics. A central software solution for the workflow management of all regular tasks is what this new generation of middleware for the microbiology lab wants to provide.
Who Should Buy? Or Key stakeholders
- Diagnostic laboratories
- Hospital & clinics
- Academic research institutes
- Physician offices
- Nursing facilities
- Home healthcare agencies
- Reference laboratories
- Others
Infectious Disease Diagnostics Market Regional Analysis
Infectious disease diagnostics market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
In 2021, North America held a commanding 35% revenue share in the market for molecular diagnostics for infectious diseases. Growing regulatory backing is to blame for this, and it is projected that rising diagnostics investment will fuel expansion. The market for infectious disease molecular diagnostics is expected to grow quickly due to factors such as the rising demand for molecular testing to identify infectious diseases, the need for early detection of infections in patients with underlying medical conditions like diabetes, and the rise in drug-resistant infections.
Asia Pacific market for infectious disease molecular diagnostics is anticipated to expand quickly over the course of the forecast period as a result of increased investments and an increase in the prevalence of infectious illnesses. The market for infectious disease molecular diagnostics is anticipated to grow in the area as a result of developments such government-provided healthcare benefits, raised public awareness, and the desire to receive top-notch medical care. Due of the high prevalence and highly inhabited locations, the COVID-19 pandemic has severely strained molecular diagnostics in this area. This region, which is dominated by China and India, is home to about half of the world’s population.
Key Market Segments: Infectious Disease Diagnostics Market
Infectious Disease Diagnostics Market By Product, 2020-2029, (USD Billion, Thousand Units)
- Reagents, Kits and Consumables
- Instruments
- Software & Services
Infectious Disease Diagnostics Market By Type Of Testing, 2020-2029, (USD Billion, Thousand Units)
- Laboratory Testing
- POC Testing
Infectious Disease Diagnostics Market By Technolgy, 2020-2029, (USD Billion, Thousand Units)
- Immunodiagnostics
- Clinical Microbiology
- PCR
- INAAT
- DNA Sequencing & NGS
- DNA Microarray
- Other Technologies
Infectious Disease Diagnostics Market By Disease Type, 2020-2029, (USD Billion, Thousand Units)
- Covid-19
- HIV
- Hepatitis
- Influenza
- Other Infectious Diseases
Infectious Disease Diagnostics Market By End User, 2020-2029, (USD Billion, Thousand Units)
- Diagnostic Laboratories
- Hospital & Clinics
- Academic Research Institutes
- Other End Users
Infectious Disease Diagnostics Market By Region, 2020-2029, (USD Billion, Thousand Units)
- North America
- Asia Pacific
- Europe
- South America
- Middle East and Africa
Important Countries in All Regions Are Covered.
Exactitude Consultancy Services Key Objectives:
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new markets
- Enhancing brand reputation
Key Question Answered
- What is the expected growth rate of the infectious disease diagnostics market over the next 7 years?
- Who are the major players in the infectious disease diagnostics market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the infectious disease diagnostics market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the infectious disease diagnostics market?
- What is the current and forecasted size and growth rate of the global Infectious disease diagnostics market?
- What are the key drivers of growth in the infectious disease diagnostics market?
- Who are the major players in the market and what is their market share?
- What are the distribution channels and supply chain dynamics in the infectious disease diagnostics market?
- What are the technological advancements and innovations in the infectious disease diagnostics market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the infectious disease diagnostics market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the infectious disease diagnostics market?
- What are the service offerings and specifications of leading players in the market?
- What is the pricing trend of infectious disease diagnostics market in the market and what is the impact of raw material prices on the price trend?
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON INFECTIOUS DISEASE DIAGNOSTICS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET OUTLOOK
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION, THOUSAND UNITS), 2020-2029
- REAGENTS, KITS AND CONSUMABLES
- INSTRUMENTS
- SOFTWARE & SERVICES
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION, THOUSAND UNITS), 2020-2029
- LABORATORY TESTING
- POC TESTING
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION, THOUSAND UNITS), 2020-2029
- IMMUNODIAGNOSTICS
- CLINICAL MICROBIOLOGY
- PCR
- INAAT
- DNA SEQUENCING & NGS
- DNA MICROARRAY
- OTHER TECHNOLOGIES
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION, THOUSAND UNITS), 2020-2029
- COVID-19
- HIV
- HEPATITIS
- INFLUENZA
- OTHER INFECTIOUS DISEASES
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION, THOUSAND UNITS), 2020-2029
- DIAGNOSTIC LABORATORIES
- HOSPITAL & CLINICS
- ACADEMIC RESEARCH INSTITUTES
- OTHER END USERS
- GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (USD BILLION, THOUSAND UNITS), 2020-2029
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES* (BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- ABBOTT LABORATORIES
- DANAHER CORPORATION
- BIOMÉRIEUX SA
- HOFFMANN-LA ROCHE LTD
- BIO-RAD LABORATORIES, INC.
- AGILENT TECHNOLOGIES, INC.
- BECTON
- DICKINSON AND COMPANY
- HOLOGIC, INC. (GEN-PROBE)
- ILLUMINA, INC.
- GRIFOLS S.A.
- QIAGEN
- SIEMENS HEALTHINEERS AG
- SYSMEX CORPORATION
*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 2 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-Â Â 2029
TABLE 3 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 4 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 5 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 6 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 7 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 8 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 9 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 10 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 11 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (USD BILLION), 2020-2029
TABLE 12 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION (THOUSAND UNITS), 2020-2029
TABLE 13 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 14 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 15 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 16 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 17 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 18 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 19 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 20 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 21 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 22 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 23 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 24 NORTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 25 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 26 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 27 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 28 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 29 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 30 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 31 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 32 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 33 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 34 US INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 35 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (BILLION), 2020-2029
TABLE 36 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 37 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 38 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 39 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 40 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 41 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 42 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 43 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 44 CANADA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 45 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 46 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 47 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 48 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 49 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 50 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 51 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 52 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 53 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 54 MEXICO INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 55 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 56 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 57 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 58 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 59 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 60 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 61 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 62 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 63 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 64 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 65 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 66 SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 67 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 68 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 69 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 70 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 71 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 72 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 73 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 74 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 75 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 76 BRAZIL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 77 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 78 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 79 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 80 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 81 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 82 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 83 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 84 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 85 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 86 ARGENTINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 87 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 88 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 89 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 90 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 91 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 92 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 93 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 94 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 95 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 96 COLOMBIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 97 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 98 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 99 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 100 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 101 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 102 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 103 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 104 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 105 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 106 REST OF SOUTH AMERICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 107 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 108 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 109 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 110 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 111 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 112 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 113 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 114 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 115 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 116 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 117 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 118 ASIA-PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 119 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 120 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 121 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 122 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 123 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 124 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 125 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 126 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 127 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 128 INDIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 129 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 130 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 131 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 132 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 133 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 134 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 135 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 136 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 137 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 138 CHINA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 139 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 140 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 141 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 142 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 143 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 144 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 145 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 146 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 147 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 148 JAPAN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 149 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 150 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 151 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 152 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 153 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 154 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 155 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 156 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 157 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 158 SOUTH KOREA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 159 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 160 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKETBY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 161 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 162 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 163 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 164 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 165 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 166 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 167 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 168 AUSTRALIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 169 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 170 SOUTH EAST ASIA AUTOMOTIVE HUDBY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 171 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 172 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 173 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 174 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 175 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 176 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 177 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 178 SOUTH EAST ASIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 179 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 180 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 181 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 182 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 183 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 184 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 185 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 186 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 187 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 188 REST OF ASIA PACIFIC INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 189 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 190 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 191 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 192 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 193 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 194 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 195 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 196 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 197 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 198 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 199 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 200 EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 201 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 202 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 203 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 204 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 205 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 206 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 207 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 208 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 209 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 210 GERMANY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 211 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 212 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 213 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 214 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 215 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 216 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 217 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 218 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 219 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 220 UK INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 221 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 222 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 223 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 224 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 225 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 226 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 227 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 228 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 229 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 230 FRANCE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 231 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 232 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 233 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 234 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 235 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 236 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 237 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 238 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 239 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 240 ITALY INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 241 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 242 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 243 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 244 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 245 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 246 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 247 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 248 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 249 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 250 SPAIN INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 251 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 252 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 253 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 254 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 255 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 256 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 257 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 258 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 259 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 260 RUSSIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 261 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 262 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 263 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 264 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 265 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 266 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 267 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 268 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 269 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 270 REST OF EUROPE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 271 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 272 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 273 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 274 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 275 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 276 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 277 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 278 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 279 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 280 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 281 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (USD BILLION), 2020-2029
TABLE 282 MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY COUNTRY (THOUSAND UNITS), 2020-2029
TABLE 283 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 284 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 285 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 286 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 287 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 288 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 289 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 290 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 291 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 292 UAE INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 293 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 294 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 295 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 296 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 297 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 298 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 299 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 300 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 301 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 302 SAUDI ARABIA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 303 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 304 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 305 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 306 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 307 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 308 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 309 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 310 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 311 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 312 SOUTH AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
TABLE 313 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (USD BILLION), 2020-2029
TABLE 314 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT (THOUSAND UNITS), 2020-2029
TABLE 315 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (USD BILLION), 2020-2029
TABLE 316 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING (THOUSAND UNITS), 2020-2029
TABLE 317 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (USD BILLION), 2020-2029
TABLE 318 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY (THOUSAND UNITS), 2020-2029
TABLE 319 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (USD BILLION), 2020-2029
TABLE 320 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY DISEASE TYPE (THOUSAND UNITS), 2020-2029
TABLE 321 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (USD BILLION), 2020-2029
TABLE 322 REST OF MIDDLE EAST AND AFRICA INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER (THOUSAND UNITS), 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS BY PRODUCT, USD BILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS BY TYPE OF TESTING, USD BILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS BY TECHNOLOGY, USD BILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS BY END USER, USD BILLION, 2020-2029
FIGURE 12Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS BY REGION, USD BILLION, 2020-2029
FIGURE 13          PORTER’S FIVE FORCES MODEL
FIGURE 14Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY PRODUCT, USD BILLION, 2021
FIGURE 15Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TYPE OF TESTING, USD BILLION, 2021
FIGURE 16Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY TECHNOLOGY, USD BILLION, 2021
FIGURE 17Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY END USER, USD BILLION, 2021
FIGURE 18Â Â Â Â Â Â Â Â Â Â GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET BY REGION 2021
FIGURE 19Â Â Â Â Â Â Â Â Â Â MARKET SHARE ANALYSIS
FIGURE 20Â Â Â Â Â Â Â Â Â Â ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â Â Â Â DANAHER CORPORATION: COMPANY SNAPSHOT
FIGURE 22          BIOMÉRIEUX SA: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â Â Â Â F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â Â Â Â BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â Â Â Â AGILENT TECHNOLOGIES, INC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â Â Â Â BECTON: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â Â Â Â DICKINSON AND COMPANY: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â Â Â Â HOLOGIC, INC: COMPANY SNAPSHOT
FIGURE 29Â Â Â Â Â Â Â Â Â Â ILLUMINA, INC.: COMPANY SNAPSHOT
FIGURE 30Â Â Â Â Â Â Â Â Â Â GRIFOLS S.A: COMPANY SNAPSHOT
FIGURE 31Â Â Â Â Â Â Â Â Â Â QIAGEN: COMPANY SNAPSHOT
FIGURE 32Â Â Â Â Â Â Â Â Â Â SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
FIGURE 33Â Â Â Â Â Â Â Â Â Â SYSMEX CORPORATION: COMPANY SNAPSHOT
FAQ
Infectious disease diagnostics market is expected to grow at 6.8% CAGR from 2022 to 2029. it is expected to reach above USD 50.31 billion by 2029
North America held more than 35% of infectious disease diagnostics market revenue share in 2021 and will witness expansion in the forecast period.
The increasing awareness of early disease detection, the frequency of infectious diseases around the world, the shift in emphasis from centralized laboratories to decentralized POC testing, and technical improvements are all factors driving market expansion.
By product the market is segmented into reagents, kits and consumables, instruments, software & services. The market was dominated by the assays & reagents segment in 2020, and this trend is anticipated to persist over the course of the forecast period due to an increase in R&D activities in the pharmaceutical & biotechnology sector, an increase in demand for reagents, and a surge in the uptake of point-of-care testing. However, the instruments market is predicted to expand significantly over the course of the projection year due to an increase in research laboratories and increased funding from public and commercial organizations for the creation of diagnostic tools for the pharmaceutical and biotechnology sectors.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.